Version 5.4
Mus musculus Protein: Naa30
Summary
InnateDB Protein IDBP-155587.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Naa30
Protein Name N(alpha)-acetyltransferase 30, NatC catalytic subunit
Synonyms 4930487N19Rik; 5730533P17Rik; AI447922; AW322455; Nat12;
Species Mus musculus
Ensembl Protein ENSMUSP00000041450
InnateDB Gene IDBG-155585 (Naa30)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004596 peptide alpha-N-acetyltransferase activity
GO:0005515 protein binding
GO:0008080 N-acetyltransferase activity
GO:0016747 transferase activity, transferring acyl groups other than amino-acyl groups
Biological Process
GO:0008152 metabolic process
Cellular Component
GO:0005737 cytoplasm
GO:0005844 polysome
GO:0031417 NatC complex
Protein Structure and Domains
PDB ID MGI:1922259
InterPro IPR000182 GNAT domain
IPR013653 FR47-like
IPR016181 Acyl-CoA N-acyltransferase
PFAM PF00583
PF13302
PF13508
PF13673
PF13718
PF08445
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E9QMB7
UniProt Splice Variant
Entrez Gene 70646
UniGene Mm.490668
RefSeq NP_001074899
MGI ID
MGI Symbol Naa30
OMIM
CCDS CCDS36902
HPRD
IMGT
EMBL AC154227
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca